Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma

British Journal of Pharmacology

Volumn 124, Issue 5, 1998, Pages 857-864

  De Bie, J J ^a   Henricks, P A J ^a   Cruikshank, W W ^b   Hofman, G ^a   Jonker, E H ^a   Nijkamp, F P ^a   Van Oosterhout, A J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 hydroxytryptamine; Asthma; Eosinophils; Histamine; Hyperresponsiveness; IgE

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHISTAMINIC AGENT; CIMETIDINE; HISTAMINE; IMMUNOGLOBULIN E; KETANSERIN; MEPYRAMINE; METITEPINE; PHENTOLAMINE; SEROTONIN; SEROTONIN ANTAGONIST;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EOSINOPHILIA; IMMUNOGLOBULIN BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031809064     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701901     Document Type: Article

References (41)

1. AMEISEN, J.-C., MEADE, R. & ASKENASE, P.W. (1989). A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. J. Immunol., 142, 3171-3179.
2. 3 receptors. Am. J. Respir. Cell Mol. Biol., 14, 620-626.
3. BLYTH, D.I., PEDRICK, M.S., SAVAGE, T.J., HESSEL, E.M. & FATTAH, D. (1996). Lung inflammation and epithelial changes in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol., 14, 425-438.
4. BRUSSELLE, G.G., KIPS, J.C., TAVERNIER, J.H., VAN DER HEYDEN, J.G., CUVELIER, C.A., PAUWELS, R.A. & BLUETHMANN, H. (1994). Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy, 24, 73-80.
5. 2 receptor, on airway responsiveness in asthma. J. Allergy Clin. Immunol., 45, 151-153.
6. CENTER, D.M., BERMAN, J.S., KORNFELD, H., THEODORE, A.C. & CRUIKSHANK, W.W. (1995). The lymphocyte chemoattractant factor. J. Lab. Clin. Med., 125, 167-172.
7. CENTER, D.M. KORNFELD, H. & CRUIKSHANK, W.W. (1996). Interleukin 16 and its function as a CD4 ligand. Immunol. Today, 17, 477-480.
8. COCKROFT, D.W & O'BYRNE, P.M. (1993). Mechanisms of airway hyperresponsiveness. In Bronchial Asthma: Mechanisms and Therapeutics (3rd edition). ed. Weiss, E.B. & Stein, M. pp. 32-42. Boston: Little Brown.
9. CORRIGAN, C.J. & KAY, A.B. (1992). T cells and eosinophils in the pathogenesis of asthma. Immunol. Today, 13, 501-507.
10. CORRY, D.B., FOLKESSON, H.G., WARNOCK, M.L., ERLE, D.J., MATTHAY, M.A., WIENER-KRONISH, J.P. & LOCKSLEY, R.M. (1996). Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med., 183, 109-117.
11. CRUIKSHANK, W.W. & CENTER, D.M. (1982). Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J. Immunol., 128, 2569-2574.
12. DE BIE, J.J., HESSEL, E.M., VAN ARK, I., VAN ESCH, B., HOFMAN, G., NIJKAMP, F.P. & VAN OOSTERHOUT, A.J.M. (1996). Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br. J. Pharmacol., 119, 1484-1490.
13. DJUKANOVIC, R., LAI, C.K.W., WILSON, K.M., BRITTEN, K.M., WILSON, S.J., ROCHE, W.R., HOWARTH, P.H. & HOLGATE, S.T. (1992). Bronchial mucosal manifestations of atopy: a comparison between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur. Respir. J., 5, 538-544.
14. DJUKANOVIC, R., ROCHE, W.R., WILSON, J.W., BEASLY, C.R.W., TWENTYMAN, O.P., HOWARTH, P.H. & HOLGAte, S.T. (1990). Mucosal inflammation in asthma. Am. Rev. Respir. Dis., 142, 434-457.
15. DOHLSTEN, M., SJÖGREN, H.O. & CARLSSON, R. (1987). Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-γ production. Cell. Immunol., 109, 65-74.
16. DRÖGE, W., SCHMIDT, H., NICK, S. & SONSKY, B. (1986). Histamine augments interleukin-2 production and the activation of cytotoxic T lymphocytes. Immunopharmacology, 11, 1-6.
17. DVORAK, A.M., TEPPER, R.I., WELLER, P.F., MORGAN, E.S., ESTRELLA, P., MONAHAN-EARLY, R.A. & GALLI, S.J. (1994). Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice: Evidence of mast cell histamine-release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood. 83, 3600-3612.
18. FUJII, E., UCHIDA, Y., TSUKAHARA, F. & MURAKI, T. (1994). 5-Hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 361-364.
19. GARSSEN, J., VAN LOVEREN, H. VAN DER VLIET, H., BOT H. & NIJKAMP, F.P. (1993). T cell-mediated induction of airway hyperresponsiveness and altered lung functions in mice are independent of increased vascular permeability and mononuclear cell infiltration. Am. Rev. Respir. Dis., 147, 307-313.
20. GOMEZ, E., CORRADO, O.J., BALDWIN, D.L., SWANSTON, A.R. & DAVIES, R.J. (1986). Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man. J. Allergy Clin. Immunol., 78, 637-645.
21. HESSEL, E.M., CRUIKSHANK, W.W., VAN ARK, I., DE BIE, J.J., VAN ESCH, B., HOFMAN, G., NIJKAMP, F.P., CENTER, D.M. & VAN OOSTERHOUT, A.J.M. (1998). Involvement of IL-16 in the induction of airway hyperresponsiveness and up-regulation of IgE in a inurine model of allergic asthma. J. Immunol., 160, 2998-3005.
22. HESSEL, E.M., VAN OOSTERHOUT, A.J.M., HOFSTRA, C.L., DE BIE, J.J., GARSSEN, J., VAN LOVEREN, H., VERHEYEN, A.K.C.P. & NIJKAMP, F.P. (1995). Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur. J. Pharmacol., 293, 401-412.
23. HESSEL, E.M., VAN OOSTERHOUT, A.J.M., VAN ARK, I., VAN ESCH, B., HOFMAN, G. VAN LOVEREN, H., SAVELKOUL, H.F.J. & NIJKAMP, F.P. (1997). Development of airway hyperresponsiveness is dependent on IFNγ and independent of eosinophil infiltration. Am. J Respir. Cell Mol. Biol., 16, 325-334.
24. HOLT, P.G., ROSE, A.H., BATTY, J.H & TURNER, K.J. (1981). Induction of adjuvant-dependent IgE responses in inbred mice: primary, secondary, and persistent IgE responses to ovalbumin and ovomucoid. Int. Arch. Allergy Appl. Immunol., 65, 42-50.
25. LABERGE, S., CRUIKSHANK, W.W., BEER, D.J. & CENTER, D.M. (1996). Secretion of IL-16 (Lymphocyte Chemoattractant Factor) from serotonin-stimulaled CD8+ T cells in vitro. J. Immunol., 156, 310-315.
26. LABERGE, S., CRUIKSHANK, W.W., KORNFELD, H. & CENTER, D.M. (1995). Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation. J. Immunol., 155, 2902-2910.
27. LABERGE, S., ERNST, P., GHAFFAR, O., CRUIKSHANK, W.W., KORNFELD, H., CENTER, D.M. & HAMID, Q. (1997). Increased expression of interleukin-16 in bronchial mucosa of subjects with asthma. Am. J. Respir. Cell Mol. Biol., 17, 193-202.
28. MARTIN, T.R., TAKEISHI, T. & KATZ, H.R. (1993). Mast cell activation enhances airway hyperresponsiveness to methacholine in the mouse. J. Clin. Invest., 1993, 1176-1182.
29. NAGAI, H., YAMAGUCHI, S., MEADA, Y. & TANAKA, H. (1996). Role of mast cells, eosinophils and IL-5 in the development of airway hvperresponsiveness in sensitized mice. Clin. Exp. Allergy, 26, 642-647.
30. OISHI, R., ADACHI, N. & SAEKI, K. (1993). N alpha-methylhistamine inhibits intestinal transit in mice by central histamine H1 receptor activation. Eur. J. Pharmacol., 237, 155-159.
31. PLAUT, M., PIECE, J.H. & WATSON, C.J. (1989). Mast cell lines produce lymphokines in response to cross-linkage of FC∈RI or to calcium-ionophores. Nature, 339, 64-67.
32. PTAK, W., GEBA, G.P. & ASKENASE, P.W. (1991a). Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. J. Immunol., 146, 3929-3936.
33. PTAK, W., HERZOG, W.-R. & ASKENASE, P.W. (1991b). Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. J. Immunol., 146, 469-475.
34. RAND, T.H. CRUIKSHANK, W.W., CENTER, D.M. & WELLER, P.F. (1991). CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligand elicit eosinophil migration. J. Exp. Med., 173, 1521-1528.
35. RANG, H.P. DALE, M.M. & RITTER, J.M. (1995). In Pharmacology (3rd edition). ed. Rang, H.P., Dale, M.M. & Ritter, J.M. New York: Churchill Livingstone.
36. ROCKLIN, R.E. & BEER, D.J. (1983). Histamine and immune modulation. Adv. Intern. Med., 28, 225-251.
37. SHAOENG, H. & WALLS, A.F. (1997). Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur. J. Pharmacol., 328, 89-97.
38. VAN OOSTERHOUT, A.J.M. & NIJKAMP, F.P. (1993). Role of cytokines in bronchial hyperresponsiveness. Pulm. Pharmacol., 6, 225-236.
39. WHITE, M.V. (1990). The role of histamine in allergic diseases. J. Allergy Clin. Immunol., 86, 599-605.
40. YOUNG, M.R.I., KUT, J.L., COOGAN, M.P., WRIGHT, M.A., YOUNG, M.E. & MATTHEWS, J. (1993). Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. immunology, 80, 395-400.
41. YOUNG, M.R.I. & MATTHEWS, J.P (1995). Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology, 84, 148-152.